Table 2.

Cox regression analysis regarding the impact of CR evaluation on OS and RFS

Non-sCR vs sCR
HR95% CI
OS   
 Crude 1.41 1.17-1.69 
 Age and sex adjusted 1.32 1.10-1.59 
 Fully adjusted* 1.34 1.10-1.64 
RFS   
 Crude 1.28 1.08-1.53 
 Age and sex adjusted 1.23 1.03-1.47 
 Fully adjusted* 1.25 1.03-1.51 
Non-sCR vs sCR
HR95% CI
OS   
 Crude 1.41 1.17-1.69 
 Age and sex adjusted 1.32 1.10-1.59 
 Fully adjusted* 1.34 1.10-1.64 
RFS   
 Crude 1.28 1.08-1.53 
 Age and sex adjusted 1.23 1.03-1.47 
 Fully adjusted* 1.25 1.03-1.51 
*

Adjusted for age, sex, World Health Organization performance score at diagnosis, leukocyte count at diagnosis, CR as response after first or second induction therapy, and cytogenetic risk group.